JENG-FAN LO

  • Publish Date：2026-07-14
  • Update Date：2026-07-15
  • Units：College of Dentistry
jelo
Jent-Fan Lo, Professor
Tel: (+886)-2-2826-7222
Fax: (+886)-2-2826-4053
E-mail: jflo@nycu.edu.tw

Research Interest
Cancer Biology, Stem Cell Biology, Mitochondrial Dysfunction, Mouse Genetics, Molecular Immunology, Animal Disease Models and Therapeutic Regimen Development




Faculty Appointments
2019 Aug-now             Distinguished Professor at National Yang Ming Chiao Tung University
2018 Aug-now              Faculty of Institute of Biochemistry and Molecular Biology, School of Life Science, National Yang Ming Chiao Tung University
2018 Aug-now              Faculty of Department and Institute of Pharmacology, School of Medicine, National Yang Ming Chiao Tung University
2014 Aug-2020 Jul       Director of Institute of Oral Biology, School of Dentistry, National Yang-Ming University
2011 Aug-now              Professor at Institute of Oral Biology, School of Dentistry, National Yang-Ming University.
2011 Aug-now              Adjunct Professor at Department of Dentistry, School of Dentistry, National Yang-Ming University.
2011 Aug-now              Adjunct Professor at Graduate Institute of Basic Medical Science, College of Medicine, China Medical University.
2008 Aug-now              Adjunct Research Fellow at Department of Dentistry, Taipei Veterans General Hospital.
2005 Aug-2011 Jul       Associate Professor at Institute of Oral Biology, School of Dentistry, National Yang-Ming University.
2008 Aug-2011 Jul       Adjunct Associate Professor at Department of Dentistry, School of Dentistry, National Yang-Ming University.
2000 Jan -2005 Mar     Research Associate (Postdoctoral Fallow) at The Scripps Research Institute, La Jolla, CA. USA. Research project: Understanding the biological function of a putative mammalian tumor suppressor through generation of a conditional knockout mice system to set up a novel cancer screen system in the future.

Education 
1994-1999     Ph.D., Department of Microbiology and Immunology, University of Illinois at Chicago. Thesis: Characterization of a silver binding protein (SilE) from the genes of Salmonella (Thesis advisor: Dr. Simon Silver).
1988-1990     M.Sc., Fu-Jen Catholic University, Taiwan. Thesis: Glutathione S-transferase p in an arsenic resistant cell line: Characterization and its role on arsenic resistance. (Thesis advisor: Dr. Te-Chang Lee).
1984-1988     B.Sc., Fu-Jen Catholic University, Taiwan

Qualifications
  1. Experienced in generating conditional knockout mice.
  2. Experienced in studying the function of a putative tumor suppressor in T cell development from T-cell-specific conditional knockout mice.
  3. Experienced in studying the function of a putative tumor suppressor in hepatocyte development and liver development from liver-specific conditional knockout mice.
  4. Familiar with mouse in vivo transgenic or chemical carcinogenesis models of cancer research: skin cancer (DMBA and TPA two-stage carcinogenesis), liver cancer (DEN or aflatoxin B1 carcinogenesis), lung cancer (transgenic k-ras carcinogenesis), breast cancer (transgenic Wap-Tg, mmtv-Her or MNU carcinogenesis) and prostate cancer (transgenic TRAMP carcinogenesis).
  5. Experienced in using small interfering RNA (siRNA) to down regulate gene expression in cell lines and chicken embryo.
  6. Experienced with using DNA Microarray and Quantitative RT-PCR to evaluate gene expression in mammalian cancer research.
  7. Proficient in molecular cloning and cell culture techniques.
  8. Proficient at using the yeast two-hybrid system to screen new targets.
  9. Experienced at using over-expression and purification of proteins from prokaryotic or eukaryotic system.
  10. Experienced with molecular biological (site direct mutagenesis) and biochemical methods (CD, AAS, NMR and fluorescence spectroscopy, etc.) to characterize purified proteins.
  11. Experienced at conducting protein structure-function studies using either crystallization or NMR.
Major research experience
  1. Isolation and characterization of cancer stem-like cells in oral cancer: Enrichment of cancer stem-like cells from oral cancer cells or primary oral cancer tissues by serum-free medium plus bFGF and EGF growth factors or side population cells (Hoechst33258 dye exclusion). Establishment of radioresistant oral cancer cells by progressive selection.
  2. Generation of different tissue specific Tid1 knockout mice by breeding Tid1-floxed mice with individual Cre transgenic mice (Lck-Cre, CD4-Cre, Alb-Cre, K14-Cre, WAP-Cre, mmtv-Cre, Syn-Cre or MX-Cre) to understand the function of DNAJA3 (Tid1) on different tissues: total RNA preparation, DNA microarray, RT-PCR, MTS or CFSE cell proliferation, flow cytometery, MTT assay, coimmunoprecipitation, Western blot, Southern blot, immunochemical staining (confocal microscopy), histology assay, mouse anatomy, blastocyst outgrowth, T cell isolation, hepatocyte isolation and keratinocyte isolation.
  3. Conditional transgenic mice establishment to study the function of DNAJA3 (Tid1) as a tumor suppressor: Genomic database search, bioinformative search, design of gene targeting vector, construction of gene targeting plasmids, screening of gene of interest from BAC genomic library, primary mouse embryonic fibroblast (MEF) and embryonic stem cell (ES) culture, DNA electroporation on ES cells, stable undifferentiated ES cell line establishment, genomic DNA preparation of ES cell, screening of homologous recombination on mouse ES cell by Southern hybridization and genomic PCR, targeted mice germ lines selection, and adenovirus or retrovirus gene delivery.
  4. Down regulation of genes expression upon inhibition of BMK1 kinase by RNA interference in cancer cell lines to elucidate the function of BMK1 on tumorigenesis: Utility of siRNA technique to down regulate the posttranscriptional mRNA of BMK1 kinase, MTT assay, total RNA preparation, DNA microarray, flow cytometery, coimmunoprecipitation and Western blot.
  5. Yeast two-hybrid to screen the erbB2 interacting proteins involving in the signal transductions of breast cancer cells: Cloning of genes of interest for yeast two-hybrid screening, yeast two-hybrid screening on high throughput 96- well format, DNA transfection of mammalian cell line, stable cell line establishment, rabbit polyclonal antibody generation, total mRNA extraction, MTT assay, b-galactosidase activity assay, adenovirus expression construct preparation and establishment, Western blot, RT-PCR, construction of cDNA library, deletion or site-directed mutagenesis, peptide mapping, phosphopeptide mapping, coimmunoprecipitation and cis or trans reporting assay (luciferase activity assay).
  6. Cloning, expression, purification and characterization of a silver binding protein (SilE) from the genes of Salmonella: Cloning of SilE over expression strain by PCR, purification of SilE by ammonium sulfate precipitation, cation exchange chromatography and gel filtration or HPLC, peptide sequencing, circular dichroism (CD) to study the secondary structure change after the binding of Ag+ to SilE, inductive coupling plasma (ICP), atomic absorption spectroscopy and mass spectroscopy to study the stoichiometry of Ag+ binding to SilE, NMR (proton or HSQC) to study the change of imidazole groups of histidine residues of SilE that are responsible for Ag+ binding and replacement of tryptophan on phenylalanine of SilE by site-directed mutagenesis to study the binding constant of SilE to Ag+ through fluorescence spectroscopy.
  7. Cloning, expression and purification of a DNA binding protein (CadC, renamed CadR) on the cadmium resistance mechanism in bacteria (Bacillus, Staphyl and methicilline resistant Staphyl): Cloning of GST-cadC fusion strain by PCR, gel retardation, probe labeling, mass growth of bacteria by fermentation, GST-CadC purification by affinity chromatography, anion exchange chromatography and gel filtration.
  8. Crystallization of mutant protein of CheY, a regulatory protein of the two-component system in E. coli: Cloning of expression plasmid, purification of over expressed protein by gel filtration (FPLC), affinity chromatography, ion exchange chromatography, SDS-PAGE, crystallization by hanging-drop and data collection on X-ray diffraction. 
  9. Selection of transformed cell line by Bovine Papilloma Virus: Cell line transfection, cell line establishment from a single colony on soft agar.
  10. Purification and characterization of Glutathione S-transferase p from an arsenic-resistant Chinese hamster ovary cell line: Cell culture, GST purification through affinity chromatography, 1D and 2D electrophoresis, characterization on enzymatic kinetics of GST-p by photospectroscopy, polyclonal antibody preparation against GST-p, Western blot, cytotoxicity assay by colony formation.

Teaching experience
2018 Feb - now             Faculty of Department and Institute of Pharmacology, School of Medicine, National Yang-Ming University. Course: Experimental Pharmacology, Special Topic on Cancer Stem Cell, Molecular Immunology and Special Topic on Mouse Transgenic.

2011 Aug - now            Professor at Institute of Oral Biology, School of Dentistry, National Yang-Ming University. Course: Advanced Biotechniques, Biochemistry, Cell Biology, Biomedical Research and Scientific Writing, Special Topic on Cancer Stem Cell, Molecular Immunology and Special Topic on Mouse Transgenic.
  
2005 Aug - 2011 Jul     Associate Professor at Institute of Oral Biology, School of Dentistry, National Yang-Ming University. Course: Advanced Biotechniques, Biochemistry, Cell Biology, Biomedical Research and Scientific Writing, Special Topic on Cancer Stem Cell, Molecular Immunology and Special Topic on Mouse Tragenics.

1996                              Teaching assistant of Department of Microbiology and Immunology, School of Medicine at University of Illinois at Chicago. Course: Laboratory of Clinical Microbiology for 2nd year medical students.

1989                              Teaching assistant of Department of Biology at Fu-Jen Catholic University, Taiwan. Course: Laboratory of Comparative Animal Anatomy.

Reviewer of finding agency
2006 to Present     Primary grant reviewer of Dentistry, Basic Medical Science, Biological Science and Biochemistry and Pharmacology, National Science and Technology Council. 
2011 to Present     Panel of Dentistry, Basic Medical Science, Clinical Medical Science and Hematology, Oncology, Infection and Immunology, National Science and Technology Council.
2018                       Swiss Cancer League

Reviewer of Peer reviewers journals
  1. ACS Nano
  2. Aging and Disease
  3. Annals of Oncology
  4. Biomedicine & Pharmacotherapy
  5. Cancer
  6. Cancer Biology and Medicine
  7. Cancer Letters
  8. Cancer Medicine
  9. Cancer Research
  10. Cell Biochemistry & Function
  11. Cellular Oncology
  12. Cell Proliferation
  13. Clinical and Translational Medicine
  14. Environmental Toxicology
  15. Evidence Based Complementary and Alternative Medicine
  16. Genes, Chromosomes and Cancer
  17. International Journal of Cancer
  18. International Journal of Biological Sciences
  19. International Journal of Molecular Sciences
  20. International Journal of Oral Science
  21. Journal of Biomedical Science
  22. Journal of Cellular Physiology
  23. Journal of Dental Sciences
  24. Journal of Experimental & Clinical Cancer Research
  25. Journal of Oral Pathology and Medicine
  26. Medicine
  27. Molecular and Cellular Biochemistry
  28. Molecular Cancer
  29. Molecular Carcinogenesis
  30. Molecular Nutrition & Food Research
  31. Molecular Medicine
  32. Neoplasia
  33. Oncogene
  34. Oncotarget
  35. PLoS One
  36. Stem Cell Research & Therapy
  37. Theranostics
  38. Tumor Biology
Honors, Prizes, Awards
  1. 2024 December-National Yang Ming Chiao Tung University Guidelines on Incentives for Ph.D. Students' Excellent Research Results “Regimen on Dnaja3 haploinsufficiency mediated sarcopenic obesity with imbalanced mitochondrial homeostasis and lipid metabolism.” (National Yang Ming Chiao Tung University, Taiwan)
  2. 2024 October-Honourable Poster Award at 2024 Annual Meeting of Taiwan Society for Mitochondrial Research and Medicine: Multifaceted & Innovative Research in Mitochondrial Medicine. “Target Screening AMPK as Stemness Markers by Single-Cell RNA Sequencing in Head and Neck Cancer Stem Cells” (Taiwan Society for Mitochondrial Research and Medicine, Taiwan)
  3. 2023 Aug – 2025 Jul-Excellence of Research Awards to Teachers in National Yang Ming Chiao Tung University (sponsored by Department of Education, ROC)
  4. 2022 May- "2022 Annual Academic Research Award - Excellent" by the National Federation of Dental Associations of the Republic of China (sponsored by Taiwan Dental Association, ROC)
  5. 2021 Aug – 2023 Jul-Excellence of Research Awards to Teachers in National Yang Ming Chiao Tung University (sponsored by Department of Education, ROC)
  6. 2019 Aug – 2021 Jul-Excellence of Research Awards to Teachers in National Yang-Ming University (sponsored by Department of Education, ROC)
  7. 2017 Aug – 2019 Jul-Excellence of Research Awards to Teachers in National Yang-Ming University (sponsored by Department of Education, ROC)
  8. 2017 Jun – 2017 Jul-Excellent Poster Award at 16th Society of Chinese Bioscientists in America (SCBA) International Symposium, and The Joseph K. K. Li Travel Award at 16th Society of Chinese Bioscientists in America (SCBA) International Symposium. “Grp78/PERK/Nrf2 signaling activation mediated metabolic reprogramming of Cancer-Initiating Cells” (Society of Chinese Bioscientists in America, USA)
  9. 2017 Jun – 2017 Jul-Excellent Poster Award at 16th Society of Chinese Bioscientists in America (SCBA) International Symposium, and The Joseph K. K. Li Travel Award at 16th Society of Chinese Bioscientists in America (SCBA) International Symposium. “Characterization and Identification of the molecular mechanism of metabolic disorder and liver cancer in hepatocyte specific Tid1 knockout mice” (Society of Chinese Bioscientists in America, USA)
  10. 2015 Aug – 2017 Jul-Excellence of Research Awards to Teachers in National Yang-Ming University (sponsored by Department of Education, ROC)
  11. 2013 Aug – 2015 Jul-Excellence of Research Awards to Teachers in National Yang-Ming University (sponsored by Department of Education, ROC)
  12. 2011 Aug – 2013 Jul-Excellence of Research Awards to Teachers in National Yang-Ming University (sponsored by Department of Education, ROC)
  13. 2011 Aug – 2012 Jul-Teaching Awards to Teachers in National Yang-Ming University (School of Dentistry, National Yang-Ming University)
Recent major Research findings 
2023/08/01~2026/07/31  Agency: NSTC (National Science and Technology Council); Title: Targeting Therapertics on Head and Neck Cancer Stem Cells by Tid1
Mediated Mitochondrial Activation (112-2314-B-A49-018 -MY3).
2021/08/01~2024/07/31  Agency: MoST (Ministry of Science and Technology); Title: Characterization of the Hepatic Tid1 Deficiency Associated Mitochondrial Dysfunction in NASH/HCC: New Insights of Pathomechanisms and Therapeutic Perspectives (110-2320-B-A49A-526 -MY3).
2019/08/01~2022/07/31  Agency: MoST (Ministry of Science and Technology); Title: Elucidation and Therapeutic Targeting of Molecular Mechanisms to Mediate Stress-Induced Cancer Stemness in Head and Neck Cancer-Initiating Cells (108-2314-B-010 -009 -MY3).
2018/08/01~2021/07/31  Agency: MoST (Ministry of Science and Technology); Title: Functional Characterization of Tid1-interacting protein galectin-7 in Head and Neck cancer metastasis (107-2314-B-010 -024 -MY3).
2017/09/01~2019/01/21  Agency: MoST (Ministry of Science and Technology); “New Partnership Program for the Connection to the Top Labs in the World” with Host PI: Dr. Xin Wei Wang, Center for Cancer Research, National Cancer Institute/National Institute of Health, Bethesda, MD, USA. Title: Therapeutic Opportunities to Liver Disorder and Targeting Tumor Initiating Cells in Hepatocellular Cancer (106-2911-I-010-513).
2016/08/01~2019/07/31  Agency: MoST (Ministry of Science and Technology); Title: Characterization and Identification of the molecular mechanism of metabolic disorder and liver cancer in hepatocyte specific Tid1knockout mice (105-2320-B-010-025-MY3).
2015/08/01~2018/07/31  Agency: MoST (Ministry of Science and Technology); Title: Functional Characterization of Antioxidant Mechanisms in Head and Neck Cancer Initiating Cells ((104-2314-B-010-047-MY3).
2014/08/01~2015/08/31  Agency: MoST (Ministry of Science and Technology); Title: Elucidating the function of Tid1 interacting proteins in carcinogenesis of head and neck squamous cell carcinoma (103-2320-B-010-028).
2014/08/01~2015/07/31  Agency: MoST (Ministry of Science and Technology); Title: Establishment of transgenic mice with deficiency of Tid1 gene specific in muscular tissue as a clinical disease model and the characterization of molecular mechanisms (103-2314-B-075-007).
2013/08/01~2014/07/31  Agency: MoST (Ministry of Science and Technology); Title: Characterization of Local Invasiveness and Chemoresistance of Head and Neck Cancer Mediated by Cancer Stem Cell (102-2314-B-010-046).
2013/08/01~2014/07/31  Agency: MoST (Ministry of Science and Technology); Title: Identification and Characterization of Active Components of Antrodia Camphorata Mycelia on Targeting Cancer Stem Cell as adjuvant therapy for head and neck cancer (102-2320-B-010-031).

Book Chapters
Teo WH., Fann YN., Lo JF*. DNAJA3, a Co-chaperone in Development and Tumorigenesis. In: Heat Shock Proteins. Springer, Dordrecht. First Online: 16 September 2020. Publisher Name Springer, Dordrecht. https://doi.org/10.1007/7515_2020_33

Selected Publications
  1. Chang CW, Chen YS, Huang CH, Lin CH, Ng WV, Chu LJ, Trépo E, Zucman-Rossi J, Siao K, Maher JJ, Chiew MY, Chou CH, Huang HD, Teo WH, Lee IS, Lo JF*, Wang XW. A genetic basis of mitochondrial DNAJA3 in nonalcoholic steatohepatitis-related hepatocellular carcinoma. Hepatology. 2025 Jan 1;81(1):60-76. (Cover story; SCI; Co-corresponding author).
  2. Fann YN, Teo WH, Lee HC, Liao CC, Tsay YG, Huang TF, Lo JF*. Regimen on Dnaja3 haploinsufficiency mediated sarcopenic obesity with imbalanced mitochondrial homeostasis and lipid metabolism. J Cachexia Sarcopenia Muscle. 2024 Oct;15(5):2013-2029. (SCI; Co-corresponding author).
  3. Sayson SL, Fan JN, Ku CL, Lo JF*, Chou SH. DNAJA3 regulates B cell development and immune function. Biomed J. 2023 Jul; 22: 100628. (SCI; Co-corresponding author).
  4. Lai KC, Regmi P, Liu CJ, Lo JF, Lee TC. IFIT2 Depletion Promotes Cancer Stem Cell-like Phenotypes in Oral Cancer. Biomedicines. 2023 Mar 14; 11(3):896.
  5. Chou YJ, Lin CC, Hsu YC, Syu JL, Tseng LM, Chiu JH, Lo JF, Lin CH, Fu SL. Andrographolide suppresses the malignancy of triple-negative breast cancer by reducing THOC1-promoted cancer stem cell characteristics. Biochem Pharmacol.  2022 Dec; 206:115327.
  6. Hung KF, Chen BH, Wang TY, Yang YP, Chien Y, Lo JF, Yang L, Peng BY, Kao SY, Wu CH. Identification of plasma hsa_circ_0000190 and 0001649 as biomarkers for predicting the recurrence and treatment response of patients with oral squamous cell carcinoma. J Chin Med Assoc.  2022 Apr 1; 85(4):431-437.
  7. Lin KH, Ali A, Kuo CH, Yang PC, Kumar VB, Padma VV, Lo JF, Huang CY, Kuo WW. Carboxyl terminus of HSP70-interacting protein attenuates advanced glycation end products-induced cardiac injuries by promoting NFκB proteasomal degradation. J Cell Physiol.  2022 Mar; 237(3):1888-1901.
  8. Ali A, Kuo WW, Kuo CH, Lo JF, Chen MYC, Daddam JR, Ho TJ, Viswanadha VP, Shibu MA, Huang CY. E3 ligase activity of Carboxyl terminus of Hsc70 interacting protein (CHIP) in Wharton's jelly derived mesenchymal stem cells improves their persistence under hyperglycemic stress and promotes the prophylactic effects against diabetic cardiac damages. Bioeng Transl Med. 2021 Jun 11; 6: e10234.
  9. Chen MC, Hsu LL, Wang SF, Pan YL, Lo JF, Yeh TS, Tseng LM, Lee HC. Salubrinal Enhances Cancer Cell Death during Glucose Deprivation through the Upregulation of xCT and Mitochondrial Oxidative Stress. Biomedicines. 2021 Aug 28; 9: 1101.
  10. Chen KY, Huang YH, Teo WH, Chang CW, Chen YS, Yeh YC Lee CJ and Lo JF*. Loss of Tid1/DNAJA3 Co-chaperone Promotes Progression and Recurrence of Hepatocellular Carcinoma after Surgical Resection: A Novel Model to Stratify Risk of Recurrence. Cancers (Basel). 2021 Jan 4; 13(1):138. (SCI; Co-corresponding author).
  11. Hung KF, Chen CY, Kawasumi M, Lan TY, Poon CL, Lin YS, Wu PJ, Chen YC, Chen BH, Wu CH, Lo JF, Weng RR and Sun YC. Adaptation to endoplasmic reticulum stress enhances resistance of oral cancer cells to cisplatin by up-regulating polymerase η and increasing DNA repair efficiency. Int J Mol Sci. 2020 December 31; 22(1):355.
  12. Teo WH, Lo JF*. Fann YN, Huang CY, Huang TF. Ganoderma microsporum immunomodulatory protein, GMI, promotes C2C12 myoblast differentiation in vitro via upregulation of Tid1 and STAT3 Acetylation. Plos One. 2020 Dec 21; 15:e0244791. (SCI; Co-corresponding author).
  13. Wang SF, Huang KH, Tseng WC, Lo JF, Li AF, Fang WL, Chen CF, Yeh TS, Chang YL, Chou YC, Hung HH, Lee HC. DNAJA3/Tid1 Is Required for Mitochondrial DNA Maintenance and Regulates Migration and Invasion of Human Gastric Cancer Cells. Cancers (Basel). 2020 Nov 20; 12(11):3463.
  14. Hung KF, Sun YC, Chen BH, Lo JF, Cheng CM, Chen CY, Wu CH, Kao SY. New COVID-19 saliva-based test: How good is it compared with the current nasopharyngeal or throat swab test? J Chin Med Assoc. 2020 Oct 1;83(10):891-894.
  15. Hu WC, Teo WH, Huang TF, Lee TC and Lo JF*. Combinatorial Low Dose Arsenic Trioxide and Cisplatin Exacerbates Autophagy via AMPK/STAT3 Signaling on Targeting Head and Neck Cancer Initiating Cells. Frontiers in Oncology. 2020 Apr 15; 10:463. (SCI; Corresponding author).
  16. Li WC, Huang CH, Shieh YT, Chen TY, Cheng LH, Chen CY, Liu CJ, Chen HM, Huang CL, Lo JF and Chang KW. Regulatory Role of Hexokinase 2 in Modulating Head and Neck Tumorigenesis. Frontiers in Oncology. 2020 Mar 31; 10:410.
Oral Presentations
  1. Fann, Y.N. and J.F. Lo. 2025.  Regimen Development on DNAJA3 Haploinsufficiency Mediated Sarcopenic Obesity and Cancer Cachexia with Imbalanced Mitochondrial Homeostasis and Lipid Metabolism. International Society for Stem Cells Research 2025 Annual Meeting, Hong Kong, China, June 11-14.
  2. Lo, J.F. Mitochondrial Dysfunction on Tumorigenesis and Normal Development.  2024. April. Innovations in Molecular Medicine: UC Davis and NYCU Research Showcase, National Yang Ming Chiao Tung University, Taipei, Taiwan.
  3. Lo, J.F. Mitochondrial Dysfunction on Tumorigenesis and Normal Development.  2022. October. College of Oral Medicine, Chun Shan Medical University, Taichung, Taiwan.
  4. Lo, J.F. Mitochondrial Dysfunction on Tumorigenesis and Normal Development.  2022. May. Keynote Speech, Bio-Nutrition Science Cultivation and Industry-University Promotion Achievement Competition and Conference, Fu-Jen Catholic University, New Taipei, Taiwan.
  5. Lo, J.F. Mitochondrial Dysfunction, Stress and Cancer Stemness on Head and Neck Carcinogenesis.  2021. September 24-25. National Health Research Institute Conference on Cancer Research, NHRI, Taiwan.
  6. Lo, J.F. Cancer Stemness, Mitochondrial Dysfunction and Stress on Tumorigenesis.  2019. November. Annual Meeting of Taiwan Society for Mitochondrial Research and Medicine, National Taiwan University, Taipei, Taiwan.
  7. Lo, J.F. Stress and Cancer Stemness on Tumorigenesis. 2019. July. 17th Society of Chinese Bioscientists in America (SCBA) International Symposium, Kunming, People Republic of China.
Poster Presentations
  1. Teo, W.H. and J.F. Lo. 2025.  Translational Value of Hepatic Dnaja3-deficient Mice in Pre-clinical Testing of Novel HCC Therapeutic. The European Association for Cancer Research (EACR) 2025 Congress, Lisbon, Portugal, June 16-19.
  2. Fann, Y.N., Yang, C.F., Wang, H.C. and J.F. Lo. 2025.  Therapeutic Regimen on A Novel Syngeneic and Cisplatin-resistant HNSCC Cachexia Model. The European Association for Cancer Research (EACR) 2025 Congress, Lisbon, Portugal, June 16-19.
  3. Ku, C.L. and J.F. Lo. 2025. Target Screening AMPK as Stemness Markers by Single-Cell RNA Sequencing in Head and Neck Cancer Stem Cells. Keystone Symposia: Mitochondrial Biology in Health and Disease. Taipei, Taiwan, January 13-16.
  4. Fann, Y.N. and J.F. Lo. 2024.  Skeletal Muscular DNAJA3 Haploinsufficiency Mediated Sarcopenic Obesity: A Novel Mouse Model for Metabolic Syndrome Study. 2024 Annual Meeting of Taiwan Society for Mitochondrial Research and Medicine, Miaoli, Taiwan, October 12.
  5. Ku, C.L. and J.F. Lo. 2024.  Target Screening AMPK as Stemness Markers by Single-Cell RNA Sequencing in Head and Neck Cancer Stem Cells. 2024 Annual Meeting of Taiwan Society for Mitochondrial Research and Medicine, Miaoli, Taiwan, October 12.
  6. Fann, Y.N. and J.F. Lo. 2022.  Characterization of Skeletal Muscular TID1 Haploinsufficiency Mediating Obesity: A Novel Mouse Model for Metabolic Syndrome Study. The 13th Congress Targeting Mitochondria Meeting, Berlin, Germany, October 26-28.
  7. Teo, W.H. and J.F. Lo. 2022.  Hepatic TID1 Deficiency in Dysregulating Mitochondrial Homeostasis and Promoting Hepatocellular Carcinoma Progression. The 13th Congress Targeting Mitochondria Meeting, Berlin, Germany, October 26-28.







 
Back